Michelle R. Cronk

Identification of genes with abnormal expression changes in acute myeloid leukemia

Derek L. Stirewalt, Soheil Meshinchi, Kenneth J. Kopecky et al. · Genes Chromosomes and Cancer · 2007 · 183 citations

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J. Sweeney, Andrew Martin, Martin R. Stockler et al. · The Lancet Oncology · 2023 · 175 citations

Urology, Oncology, Genitourinary Cancer +7

Crystal structure of E. coli β–carbonic anhydrase, an enzyme with an unusual pH–dependent activity

J.D. Cronk, James A. Endrizzi, Michelle R. Cronk et al. · Protein Science · 2001 · 154 citations · Full text

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin

Roland B. Walter, Brian W. Raden, Michelle R. Cronk et al. · Blood · 2004 · 92 citations

PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism

Roland B. Walter, Jason Pirga, Michelle R. Cronk et al. · Blood · 2005 · 51 citations · Full text